RNU7-57P

Across TCGA pan-cancer cohorts, RNU7-57P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-57P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNU7-57P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-57P expression acts as an unfavorable survival marker.

LUSC, UCEC, and LUAD are the cancer types where RNU7-57P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	90	view →
UCEC	OS	Tertile	III,IV	0.232	0.833	<.001	90	view →
LUAD	OS	Tertile	All	0.035	0.812	<.001	36	view →
SARC	DFS	Tertile	All	0.109	0.591	.020	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-57P–LUSC (DFS)

Open the LUSC breakdown →